BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16966251)

  • 1. Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin's lymphoma.
    Vassilakopoulos TP; Angelopoulou MK; Pangalis GA
    Leuk Lymphoma; 2006 Aug; 47(8):1450-1. PubMed ID: 16966251
    [No Abstract]   [Full Text] [Related]  

  • 2. Nodular lymphocyte-predominant Hodgkin's lymphoma.
    Nogovà L; Diehl V; Engert A;
    Curr Hematol Malig Rep; 2006 Mar; 1(1):60-5. PubMed ID: 20425333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular lymphocyte predominant Hodgkin's disease.
    Portlock CS
    Cancer Treat Res; 2006; 131():353-62. PubMed ID: 16704176
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte-predominant Hodgkin's lymphoma.
    Horwich A; Cunningham D
    J Clin Oncol; 2010 Jul; 28(19):e325; author reply e326. PubMed ID: 20516449
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
    Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
    J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease in children.
    Pao WJ; Kun LE
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):345-65. PubMed ID: 2663832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
    Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
    Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte-predominant Hodgkin's disease: how little therapy is enough?
    Aster JC
    J Clin Oncol; 1999 Mar; 17(3):744-6. PubMed ID: 10071261
    [No Abstract]   [Full Text] [Related]  

  • 12. Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network.
    Farrell K; McKay P; Leach M
    Leuk Lymphoma; 2011 Oct; 52(10):1920-8. PubMed ID: 21663507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special issues in pediatric Hodgkin's disease.
    Schwartz CL
    Eur J Haematol Suppl; 2005 Jul; (66):55-62. PubMed ID: 16007870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?
    Canellos GP; Mauch P
    J Clin Oncol; 2010 Jan; 28(1):e8. PubMed ID: 19933898
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
    McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
    Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
    [No Abstract]   [Full Text] [Related]  

  • 16. Winning the battle against Hodgkin's disease.
    Consalvo K; Gallagher M
    RN; 1986 Dec; 49(12):20-5. PubMed ID: 3642697
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
    Ali A; Sayed H; Farrag A; El-Sayed M
    Leuk Res; 2010 Nov; 34(11):1447-52. PubMed ID: 20599270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guideline for childhood Hodgkin's lymphoma].
    ;
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):586-9. PubMed ID: 25224235
    [No Abstract]   [Full Text] [Related]  

  • 19. New therapies in Hodgkin's lymphoma.
    Bartlett N
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):80, 83. PubMed ID: 16163165
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathology of Hodgkin's lymphoma.
    Eberle FC; Mani H; Jaffe ES
    Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.